AstraZeneca CEO Talks Drug Sales in US
Bloomberg Talks
00:00
China's Rise in Pharma Innovation
This chapter explores China's transformation from generics production to a key player in drug development, driven by returning scientists and investment opportunities. It analyzes the challenge for U.S. firms to maintain leadership while adapting strategies to attract investments and focus on patient needs amid growing competition.
Transcript
Play full episode
